ArticleScientific reports2020

Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights.

Mohammed Moustapha Anwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.